FDA Panel Unanimously Recommends Eli Lilly’s Alzheimer’s Drug

This post was originally published on Forbes Middle East

A Food and Drug Administration advisory panel unanimously voted Monday to recommend Eli Lilly’s Alzheimer’s drug donanemab for approval.

…